Skip navigation
Navigation skipped

News Releases

Harris Nesbitt to Webcast Investor Conference on the Healthcare Industry  

Harris Nesbitt, the U.S. investment banking arm of BMO Financial Group, is proud to present its 4th annual conference on the Healthcare industry starting on Wednesday, December 8 at 8:00 a.m. at The Metropolitan Club in New York City. 

The institutional investor event brings together more than 50 leading and emerging companies in the pharmaceutical, biotechnology, life sciences and medical technology industries. Hosted by Harris Nesbitt equity research analysts John Boris (pharmaceuticals), Thomas Shrader (biotechnology) and Joanne Wuensch (medical technologies and devices), the event features a unique mix of company presentations followed by an interactive question and answer period.

All presentations will be webcast live and can be accessed at:

www.harrisnesbitt.com/conferences/healthcare2004

Scheduled presenters and times are*:

Time

Track 1

Track 2

Track 3

Track 4

Track 5

8:00 a.m.

Nabi Biopharmaceuticals (NABI)

Mark Smith, SVP Finance, Treasurer & CFO

Stryker (SYK)

John Brown, Chairman & CEO

Medtronic (MDT)

Rachel Scherer, VP, IR

Curis (CRIS) Daniel, Passeri, President & CEO

Michael Gray, VP Finance & CFO

LCA Vision (LCAV)

Alan Buckey, EVP, Finance

8:45

Dyax (DYAX)

Henry Blair, Chairman, President & CEO

St. Jude Medical (STJ)

Laura Merriam, Director, IR

Inhibitex (INHX)

Joseph Patti, VP, Preclinical Dev., CSO

Russell Plumb, CFO & VP of Finance & Admin

Integra LifeSciences (IART)

Gerry Carlozzi, EVP & COO

CryoCath Technologies (CYT)

Steven Arless, President & CEO

9:30

Genzyme (GENZ)

Elliot Hillback, SVP Corp. Affairs

Alcon (ACL)

Kurtis Klein, VP, General Manager Consumer Products Div.

Oscient (OSCI)

Steven Rauscher, CEO & President

Cortex Pharmaceuticals

(COR)

Roger Stoll, Chairman, President & CEO

Aphton (APHT)

Patrick Mooney, President & CEO

10:15

Alexion (ALXN)

Lenny Bell, CEO

Discovery Labs (DSCO)

Robert Capetola, President & CEO

ArthroCare (ARTC)

Michael Baker, President & CEO

Fernando Sanchez, SVP & CFO

Conceptus (CPTS)

Gregory Lichtwardt, EVP, Treasurer & CFO

Kosan (KOSN)

Robert Johnson, Jr. EVP, Development & Chief Medical Officer

Time

Track 1

Track 2

Track 3

Track 4

Track 5

11:00

Gilead Sciences (GILD)

Mark Perry, Sr. Business Advisor

Zimmer (ZMH)

Raymond Elliott, Chairman, President & CEO

Advanced Medical Optics (AVO)

Russ Trenary, Corp. VP & Chief Marketing Officer

Sheree Aronson, VP Corp. Comm & IR

Northfields Labs (NFLD)

Steven Gould, Chairman & CEO

Praecis (PRCS)

Kevin McLaughlin, President, COO & Director

11:45

Vertex (VRTX)

Ian Smith, SVP & CFO

Eyetech (EYET)

David Guyer, CEO

ResMed (RMD)

David Pendarvis, VP Global General Counsel

CardioDynamics (CDIC)

Michael Perry, CEO & Director

AMN Healthcare (AHS)

Susan Nowakowski, President & COO

12:30

Tercica (TRCA)

Tim Lynch, CFO

Ross Clark, CTO and Founder

Cubist (CBST)

Mike Bonney, President & CEO

Respironics (RESP)

John Miclot, President & CEO

Dan Bevevino, VP & CFO

Oxigene

Frederick Driscoll, President & CEO

Keryn Biopharmaceuticals Inc.

Michael Weiss, Chairman & CEO

1:15

Vicuron (MICU)

Dov Goldstein, EVP, Finance & CFO

TriPath Imaging (TPTH)

Stephen Hall, CFO & SVP

QLT (QLTI)

Mohammed Azab, EVP Research & Development & CMO

Allied Healthcare (AHCI)

Sarah Eames, EVP

Indevus (IDEV)

Michael Rogers, EVP & CFO

2:00

Chiron (CHIR)

Joel Jung, VP & Treasurer

Mannkind (MNKD)

Hakan Edstrom, President, COO & Director

Bausch & Lomb (BOL)

Stephen McCluski, SVP & CFO

Barbara Kelley, Director, IR

Daniel Ritz, Director, IR

Vivus (VVUS)

Leland Wilson, President & CEO

Timothy Morris, VP of Finance & CFO

Emisphere Technologies (EMIS)

Michael Goldberg, CEO

2:45

InterMune (ITMN)

Norman Halleen, SVP Finance & CFO

Steven Porter, SVP Clinical Affairs

AVANT Immunotherapeutics

Avery Caitlin, SVP & CFO

AnorMED (AOM)

Michael Abrams,

President & CEO

Cross Country (CCRN)

Joseph Boshart, President & CEO

Howard Goldman, Director, IR

Concept Therapeutics (CORT)

Fred Kurland, CFO

*Agenda subject to change.

About Harris Nesbitt

Harris Nesbitt is an investment and corporate bank offering clients access to a full range of products and services including investment and corporate banking, treasury services, market risk management, institutional investing and research. Harris Nesbitt is part of Harris, an integrated financial services organization providing more than 1.5 million personal, business, corporate and institutional clients with banking, lending, investing and financial management solutions. Harris is a member of BMO Financial Group (NYSE, TSX: BMO). For more information, please visit www.harrisnesbitt.com.

- 30 -

For further information: